RhumbLine Advisers’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
Other funds holding NERV
RhumbLine Advisers's NERV Position: Q3 2026 in Review
RhumbLine Advisers increased its Minerva Neurosciences (NERV) stake by 44% in Q3 2026, buying an estimated $56.7K and bringing the position to 43,101 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #3401.
RhumbLine Advisers first reported a position in NERV in Q2 2016 and has held it in 22 quarters since. The position peaked at $346K in Q3 2018. 58 funds tracked by Wall St. Rank hold NERV as of Q3 2026.
- RhumbLine Advisers held 43,101 shares of Minerva Neurosciences worth $144K as of Q3 2026.
- RhumbLine Advisers bought 13,234 Minerva Neurosciences shares in Q3 2026, an estimated $56.7K.
- Minerva Neurosciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #3401 holding.
- RhumbLine Advisers first reported a position in Minerva Neurosciences in Q2 2016 and has held it in 22 quarters since.
- RhumbLine Advisers's Minerva Neurosciences position peaked at $346K in Q3 2018.
- 58 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.